globalbarry. Company Intelligence Engine

Revance Therapeutics, Inc.

CIK0001479290 CIK 0001479290 · Pharmaceutical Preparations (SIC 2834)

Disclosed SEC business address
1222 DEMONBREUN STREET, SUITE 2000, NASHVILLE, TN, 37203

Revance Therapeutics, Inc. (ticker CIK0001479290, CIK 0001479290) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.

Top findings public preview

  • FACT Disclosed industry: Pharmaceutical Preparations (SIC 2834)
  • FACT Country of disclosed business address: United States
  • FACT SCHEDULE 13G/A filed 2025-05-15 source ↗

Go deeper

This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 0 free company deep views left this month.

Sources

Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.